When Lori Robertson learned about her rare bile duct cancer had not only returned several years after undergoing surgery but had also spread to the lining of her abdomen, she was shocked. Her doctor offered her the chance to enroll in a phase 1 clinical trial, an early-stage research study that investigates the ideal dose for a potential new drug.
MENU
